The traditional healthcare system offered a reactive model: when you fall ill, you visit a…
TechPharus
Latest Posts
Blueprint for Tomorrow: Abu Dhabi’s Genomic Vision for Healthcare
Abu Dhabi is leading a genomic revolution that promises to reshape healthcare by deeply understanding…
The UAE’s Expanding Life Sciences Ecosystem: A New Global Powerhouse
The UAE’s healthcare and life-science sector is experiencing rapid growth, powered by a robust ecosystem…
Building the Future of Pharma: Abu Dhabi’s Strategic Leap
Abu Dhabi’s Pharmaceutical Sector: Rising to Global Prominence Over the past decade, Abu Dhabi—one of…
How the UAE is Shaping the Future of Longevity and Healthspan
The United Arab Emirates is swiftly positioning itself as a global leader in the Longevity…
Interview with Dr. Priyanka Mathur, MediPocket World
We recently spoke to Dr. Priyanka Mathur, a visionary healthcare leader with international healthcare experience…
HealthTech News
- From 7,000 drugs to one active against resistant strains: AI advances pneumonia drug repurposingon September 16, 2026 at 7:10 am
Streptococcus pneumoniae is a bacterial pathogen that causes life-threatening infections, including pneumonia and meningitis. These infections are commonly treated with antibiotics, but antibiotics are becoming less effective against S. pneumoniae over time because of changes in the pathogen that cause drug resistance. This phenomenon, called antimicrobial resistance, is resulting in significant health care costs and deaths around the world. In a new study published by Wiley in Advanced Science, researchers used artificial intelligence (AI) to identify approved drugs that may be effective against S. pneumoniae.
- AACR’s annual cancer progress report highlights promising advances for patientson September 16, 2026 at 4:00 am
The American Association for Cancer Research (AACR) has released the 16th edition of its annual Cancer Progress Report. This comprehensive report provides current data on cancer incidence, mortality and survivorship. It also outlines how basic, translational and clinical cancer research and cancer-related population science—largely supported by federal investments in the National Institutes of Health (NIH), the National Cancer Institute (NCI), the U.S. Food and Drug Administration (FDA), and the Centers for Disease Control and Prevention (CDC)—are improving health and saving lives.
- Brain MRI surveillance without prophylactic cranial irradiation improves cognitive outcomes in small cell lung canceron September 16, 2026 at 3:40 am
In the SWOG S1827 MAVERICK Phase III randomized trial, patients with small-cell lung cancer (SCLC) who underwent regular brain MRI surveillance without prophylactic cranial irradiation (PCI) had significantly better cognitive failure-free survival (the primary endpoint of the trial), without an apparent difference in overall survival, according to results presented at the Presidential Symposium of the IASLC 2026 World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer, in Seoul, South Korea.
- New model tracks vocal fold fatigue as it develops, study showson September 16, 2026 at 3:00 am
A new approach to modeling vocal fold fatigue could improve detection and monitoring of problems as they arise, particularly among people whose jobs depend on sustained voice use. The research, published in the International Journal of Information and Communication Technology, uses a physics-based framework to track changes over time.
- STI rates remain high in Australia’s latest sexual health dataon September 16, 2026 at 2:40 am
New sexual health data released by the Kirby Institute at UNSW Sydney show a mixed picture for Australia, with rates of syphilis and gonorrhea remaining high after significant increases since 2016—and chlamydia stable but still the most commonly notified sexually transmitted infection (STI). First Nations peoples continue to experience higher rates of all STIs, highlighting the need for sustained investment in culturally safe sexual health services.




